Anthem Biosciences LimitedShare price targets & analyst calls
₹934.05-16.65 (-1.75%)
As of 4 Sept 2026
Analysts lean BUY·all 2 long-term calls are BUY·consensus 1Y target ₹1,025 (9.7% above CMP)
₹1,025
9.7% above CMP
₹1,000 – ₹1,050
2 active 1Y targets
6 open
6 BUY · 0 SELL (all horizons)
N/A
9 of 10 closed calls needed
Watch ANTHEM for new buy/sell callsGet alertsSee 52 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
All tips (17) · loading…
BUYANTHEMAnthem BiosciencesHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance) · 12 mo left
AI2+·0−+4.6% P&L+12.4% upside left
₹934.05
CMP
Entry*
₹893
Target
₹1,050
JIJefferies India· via Zee Business (Live)2w ago
BUYANTHEMAnthem BiosciencesHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance) · 11 mo left
AI2+·0−+19.6% P&L+7.1% upside left
₹934.05
CMP
Entry
₹781
Target
₹1,000
AJAnshul Jain, Lakshmishree Investment and Securities· via Business Today6w ago
AI5+·0−+22.37% realised0.0% upside left
Entry*
₹760
Target
₹930
hit 27 Aug 2026, 12:08 pm
SSSiddharth Sedani, Anand Rathi· via Zee Business (Live)8w ago
BUYANTHEMAnthem BiosciencesHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI9+·0−+17.02% realised0.0% upside left
Entry*
₹769.1
Target
₹900
hit 17 Aug 2026, 12:08 pm
BCBOB Capital Markets· via Institutional / Brokerage Research15w ago
BUYANTHEMAnthem BiosciencesHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI3+·1−+19.07% realised0.0% upside left
Entry*
₹701.25
Target
₹835
hit 4 Aug 2026, 12:08 pm
BCBOB Capital Markets· via Institutional / Brokerage Research27w ago
BUYANTHEMAnthem BiosciencesHorizon: 1–3 Months* (horizon not stated by the source; assumed from the target's distance)Target hit
AI11+·2−+13.64% realised0.0% upside left
Entry*
₹748
Target
₹850
hit 10 Aug 2026, 12:08 pm
PLPrabhudas Lilladher· via Economic Times New Stock Recos8w ago
-2.34% realisedNA upside left
SL
₹750
Entry
₹768
Target
₹810
hit 8 Jun 2026, 2:36 pm
VSVikas Sethi, Sethi Finmart· via Zee Business (Live)12w ago
BUYANTHEMAnthem BiosciencesHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance) · 10d left
AI2+·1−+0.1% P&L+4.9% upside left
₹934.05
CMP
SL
₹885
Entry*
₹932.7
Target
₹980
KBKush Bohra· via NDTV Profit (Live)4d ago
BUYANTHEMAnthem BiosciencesHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance) · 10d left
AI2+·1−-0.4% P&L+6.0% upside left
₹934.05
CMP
SL
₹910
Entry*
₹938.05
Target
₹990
ABAshish Bahety, Profitmart Securities· via CNBC Awaaz.4d ago
BUYANTHEMAnthem BiosciencesHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance) · 2d left
AI2+·1−+1.5% P&L+3.3% upside left
₹934.05
CMP
SL
₹885
Entry*
₹920
Target
₹965
AKAshish Kyal, Waves Strategy Advisors· via CNBC Awaaz.1w ago
BUYANTHEMAnthem BiosciencesHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance) · 2d left
AI2+·1−+3.3% P&L+5.5% upside left
₹934.05
CMP
SL
₹875
Entry*
₹904.4
Target
₹985
DMDeven Mehata, IDBI Capital Markets and Securities· via CNBC Awaaz.1w ago
BUYANTHEMAnthem BiosciencesHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
AI2+·1−+5.04% realised0.0% upside left
SL
₹889
Entry
₹912
Target
₹958
hit 4 Sept 2026, 9:15 am
ICIDBI Capital· via IDBI Capital Research Calls Telegram5d ago
BUYANTHEMAnthem BiosciencesHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
AI2+·1−+2.91% realised0.0% upside left
SL
₹885
Entry*
₹928
Target
₹955
hit 4 Sept 2026, 9:15 am
AKAshish Kyal, Waves Strategy Advisors· via CNBC Awaaz.1w ago
BUYANTHEMAnthem BiosciencesHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Expired○ No trade
AI10+·1−— realisedNA upside left
Entry
₹800
Target
₹999
SJSachin Janardan Sarvade, IDBI Capital Markets and Securities· via NDTV Profit (Live)3w ago
AI10+·1−-0.40% realisedNA upside left
₹874.95
At expiry
Entry*
₹878.5
Target
₹919
expired 25 Aug 2026, 3:30 pm
SJSachin Janardan Sarvade, IDBI Capital Markets and Securities· via NDTV Profit (Live)3w ago
AI10+·1−— realisedNA upside left
Entry
₹800
Target
₹990
SJSachin Janardan Sarvade, IDBI Capital Markets and Securities· via NDTV Profit3w ago
BUYANTHEMAnthem BiosciencesHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Expired
AI9+·1−+5.63% realisedNA upside left
₹874.65
At expiry
SL
₹800
Entry*
₹828
Target
₹950
expired 20 Aug 2026, 3:30 pm
ABAshish Bahety, Profitmart Securities· via CNBC Awaaz.4w ago